Could a mild brain zap boost learning in kids with autism?
NCT ID NCT07092280
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a safe, low-level brain stimulation technique called tDCS can help children with autism who are not making enough progress in their learning programs. The study will involve 24 children aged 5 to 12 who are already in behavioral therapy. They will receive tDCS alongside their usual therapy to see if it improves thinking skills and reduces autism symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 24 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Males and females between 5 and 12 years with autism 2. Enrolled in an ABA program (school or in-home) supervised by a Board Certified Behavior Analyst (BCBA) 3. Stable medical and behavioral treatments for at least 4 weeks prior to, and during the study 4. Able to tolerate wearing tDCS as determined during a week-long daily desensitization training. Exclusion Criteria: 1. Any implanted metal device (heart pacemaker, cochlear implant, surgical clips, etc.) 2. Severe neurological disorders such as TBI, brain tumor, intracranial infection 3. Seizure disorder with a seizure within the last two years 4. Skull defect 5. Peripheral blindness or deafness 6. Medication that might affect tDCS: There have been a few studies concerning the effect of various medications on tDCS. Some may block and others may enhance the effects depending on many factors. The assay used to test these medications was its effect on the motor cortex after stimulation and this may not apply to our montages, however, in order to minimize the chances of having medication affect our results, participants taking the following medications will be excluded: * Na or Ca channel blockers which will include all anti-seizure medications * Medications that affect the NMDA receptors including dextromethorphan, cycloserine * Serotonin reuptake inhibitors * Dopamine stimulating or blocking medications including pergolide, bromocriptine and all antipsychotic medications * Norepinephrine stimulating or blocking agents including propranolol and the stimulants * Drugs that can lower seizure threshold \[imipramine, amitriptyline, doxepin, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, phencyclidine, ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline\] * Barbiturates, benzodiazepines, meprobamate, chloral hydrate in the past 4 weeks 7. Acute skin disease 8. History of magnetic or electrical stimulation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
New York State Institute for Basic Research
RECRUITINGStaten Island, New York, 10314, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can wireless monitors make ER vitals easier for autistic children?
- Why do some children with autism struggle with balance?
- Brain zaps tested to calm emotional storms in autism
- Can an AI chatbot help autism caregivers find their way?
- Pregnancy and birth clues: what raises autism risk?
- Can virtual reality boost thinking skills in kids with autism?